Clinical Trial

A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

Name: A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis — clinical trial record (NCT07106372)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multi-center, single-arm, open-label phase 3 study to evaluate the safety, efficacy, Pharmacokinetics(PK) and immunogenicity of Stapokibatrt in children with Atopic Dermatitis.

Trial Details

NCT Number	NCT07106372
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Atopic Dermatitis
Enrollment	240 participants
Start Date	2025-09
Primary Completion	2027-02 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-06